Participants 269 325 6
patients with EGFR mutation-positive lung adenocarcinoma
Participants 411 564 6
Previously untreated patients with EGFR mutation-positive stage IIIB or IV lung adenocarcinoma were enrolled in LUX-Lung 3 (n=345) and LUX-Lung 6 (n=364)
Participants 2753 2824 4
229 patients in LUX-Lung 3 and 35 [15%] of 239 patients in LUX-Lung 6),
Participants 3523 3561 3
patients with Leu858Arg EGFR mutations
